BRD7389 is a specific RSK family kinase inhibitor with IC 50 s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1 , RSK2 , and RSK3 , respectively. BRD7389 is a small-molecule inducer of insulin expression in pancreatic α-cells.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Obesity | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Signaling Pathways > Ribosomal S6 Kinase (RSK)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.